Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Frailty × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14 Genitourinary 7 Other hematologic neoplasm 5 Gynecologic 4 Breast 4 Thoracic 1 Plasma cell 1 NET 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 338 Multiple Endocrine Neoplasia Type 1 137 Carcinoma, Neuroendocrine 103 Pituitary Neoplasms 94 Thyroid Cancer, Papillary 93 Thyroid Neoplasms 78 Pheochromocytoma 72 Carcinoid Tumor 65 Neoplasms 64 Adrenocortical Carcinoma 61 Thyroid Carcinoma, Anaplastic 59 Paraganglioma 52 Neoplasm Metastasis 44 Carcinoma, Non-Small-Cell Lung 44 Carcinoma, Medullary 44 Adenocarcinoma, Follicular 40 Insulinoma 39 Colorectal Neoplasms 39 Adenoma, Islet Cell 39 Pancreatic Neoplasms 38 Small Cell Lung Carcinoma 35 Gastro-enteropancreatic neuroendocrine tumor 34 Breast Neoplasms 34 Sarcoma 33 Adrenal Gland Neoplasms 33 Somatostatinoma 30 Prostatic Neoplasms 30 Melanoma 30 Carcinoma, Renal Cell 30 Head and Neck Neoplasms 29

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡